Menu
/REGISTER
Montecito
Tolman Wiker
Pac Premier
Fielding
Farmers merchants
Nixon Peabody
Express Pros
Loading...
You are here:  Home  >  Biotech  >  Current Article

Sienna Biopharmaceuticals filing for Chapter 11 bankruptcy

By   /   Tuesday, September 17th, 2019  /   No Comments

    Print       Email
Westlake Village-based dermatology biotech Sienna Biopharmaceuticals announced Sept. 17 that it will file Chapter 11 bankruptcy to restructure the company. Shares plunged 65 percent on the news, falling to just 24 cents as of 10 a.m., for a market capitalization of $7.4 million. The company had previously announced that it was considering a range of…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

MindBody invests in healthy living platform Fitt

Read More →